Sage Journals: Discover world-class research

Free access

Research article

First published 2002-5

Ritonavir/Saquinavir plus One Nucleoside Reverse Transcriptase Inhibitor (NRTI) versus Indinavir plus Two Nrtis in Protease Inhibitor-Naive HIV-1-Infected Adults (Iris Study)

Eric Florence, Christa Dreezen, Patrick Desmet [...]

Antiviral Therapy

Retricted access

Research article

First published 2016-3

Reporting on Adverse Clinical Events

Clin-Alert

Free access

Research article

First published 2003-8

A Randomized Trial Comparing Initial Haart Regimens of Nelfinavir/Nevirapine and Ritonavir/Saquinavir in Combination with Two Nucleoside Reverse Transcriptase Inhibitors

Ole Kirk, Jens D Lundgren, Court Pedersen [...]

Antiviral Therapy

Free access

Research article

First published 2003-7

A Once-Daily Haart Regimen Containing Indinavir + Ritonavir plus One Or Two Nucleoside Reverse Transcriptase Inhibitors (Pipo Study)

David M Burger, Rob E Aarnoutse, Jeanne P Dieleman [...]

Antiviral Therapy

Retricted access

Research article

First published 2011-4

Reporting On Adverse Clinical Events

Clin-Alert

Free access

Research article

First published 2015-7

Pharmacokinetics,Safety and Efficacy of Ritonavir-Boosted Atazanavir (300/100 mg Once Daily) in HIV-1-Infected Pregnant Women

Minh P Lê, Laurent Mandelbrot, Diane Descamps [...]

Antiviral Therapy

Retricted access

Research article

First published 2012-3

Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study

G Blick, P Greiger-Zanlungo, S Gretz [...]

International Journal of STD & AIDS

Free access

Research article

First published 2017-4

Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Antiretroviral-Experienced Subjects: Week 48 Analysis of AI438011,a Phase IIb,Randomized Controlled Trial

the AI438011 study team, Melanie Thompson, Jacob P Lalezari [...]

Antiviral Therapy

Retricted access

Research article

First published 2012-10

A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial to Assess Efficacy and Safety Profile: The KITE Study

Ighovwerha Ofotokun, Anandi N. Sheth, Sara E. Sanford [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2006-11

Long-Term Immunologic Outcome in HAART-Experienced Subjects Receiving Lopinavir/Ritonavir

Marco Bongiovanni, Teresa Bini, Maddalena Casana [...]

AIDS Research and Human Retroviruses

Search results